See also our related blogs for the Keller Laboratory and the Pediatric Preclinical Testing Initiative.

Thursday, May 31, 2012

Lyla Nsouli Foundation funds academic – pharma pilot study

The Lyla Nsouli Foundation is proud to announce the award of a 67,000 USD pilot grant to Dr. Sakir ‘Hume’ Gultekin, Neuropathologist and Associate Professor of Pathology, Oregon Health & Science University.  In this pilot study, Dr. Gultekin will examine a new set of cell surface receptors in diffuse intrinsic pontine glioma (DIPG) to determine whether their co-expression matches a profile consistent with novel therapeutic targets. While at the earliest stage of preclinical development, it is hoped that novel targets and unique therapeutic approaches might lead to a clinical trial for children with DIPG in the foreseeable future.  

Thursday, May 10, 2012

(re-posted from the AYA Voice)

In a joint effort with our community partners, Familias en Accion and Oncology Youth Connection, the Adolescent and Young Adult Oncology Program will begin our Cancer Transitions sessions. The program aims to help young adult patients (aged 18-39 at time of session start) with cancer, who are transitioning from active treatment to survivorship. Participants need to have completed treatment in the last two years. Beginning Thursday, May 24, 2012, the six-week program will focus on a new area of survivorship each week, providing information on things like tips for healthy eating, how to keep exercise in a busy schedule, and how to take control of survivorship. We’ll also provide tools for working through the emotional and social hurdles faced during the transition period after treatment, as well as give AYAs a chance to connect with others and learn they are not alone. So if you are a survivor, or you know someone who could benefit from this FREE program, please email Mindy or call 503-494-0446 to get more information or to register. Space is limited.
Adolescents and young adults with cancer have different needs from other patients. The Knight Cancer Institute is proud to offer Oregon's only program designed exclusively for people ages 15-39. Our internationally-recognized, award-winning Adolescent and Young Adult Oncology Program is dedicated to ensuring all AYAs with cancer have access to services tailored to their specific needs.

Wednesday, May 2, 2012

Dr. Langenau gives Scott Michael Carter Memorial Lectureship

We are excited to welcome MGH cancer researcher, Dr. David Langenau, 4pm on Tuesday May 6 to present the second annual Scott Michael Carter Memorial Lectureship, “Self-renewal mechanisms in T-cell Leukemia and Rhabdomyosarcoma”.  The Knight Cancer Institute seminar series lecture will be held in the OHSU Main Hospital auditorium, room 8B60.  
For more information on the Scott Carter Foundation, and Scott's selfless legacy, click here.  
Live stream 4pm PST:  click here